- Dopamine Agonist Therapy in Advanced Parkinson’s Disease
-
Heinz Reichmann
-
J Mov Disord. 2009;2(1):10-13.
-
DOI: https://doi.org/10.14802/jmd.09003
-
-
37,200
View
-
133
Download
-
3
Crossref
-
PDF
-
Citations
Citations to this article as recorded by 
- A Review of Advanced Molecular Engineering Approaches to Enhance the Thermostability of Enzyme Breakers: From Prospective of Upstream Oil and Gas Industry
Muhammad Naeem, Amjad Bajes Khalil, Zeeshan Tariq, Mohamed Mahmoud International Journal of Molecular Sciences.2022; 23(3): 1597. CrossRef - ‘Dopamine agonist Phobia’ in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine
Silvia Rota, Iro Boura, Lucia Batzu, Nataliya Titova, Peter Jenner, Cristian Falup-Pecurariu, K Ray Chaudhuri Expert Review of Neurotherapeutics.2020; 20(9): 953. CrossRef - The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease
Sara Lorio, Fabio Sambataro, Alessandro Bertolino, Bogdan Draganski, Juergen Dukart Frontiers in Aging Neuroscience.2019;[Epub] CrossRef
|